Farhad Sahebkar

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Quality Improvement

Gestational Age

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D Park, Pilar Pichon Zentil, Anup D Patel, Elizabeth A Thiele, Robert T Wechsler, Daniel Checketts, Farhad Sahebkar
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. Epilepsia 64 (3) (2023)
Jerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D Park, Pilar Pichon Zentil, Anup D Patel, Elizabeth A Thiele, Robert T Wechsler, Daniel Checketts, Farhad Sahebkar
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. Epilepsia 64 (3) (2023)
Jerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D Park, Pilar Pichon Zentil, Anup D Patel, Elizabeth A Thiele, Robert T Wechsler, Daniel Checketts, Farhad Sahebkar
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. Epilepsia 64 (3) (2023)
Jerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D Park, Pilar Pichon Zentil, Anup D Patel, Elizabeth A Thiele, Robert T Wechsler, Daniel Checketts, Farhad Sahebkar
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. Epilepsia 64 (3) (2023)
Jerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D Park, Pilar Pichon Zentil, Anup D Patel, Elizabeth A Thiele, Robert T Wechsler, Daniel Checketts, Farhad Sahebkar
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. Epilepsia (2022)
Jerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D Park, Pilar Pichon Zentil, Anup D Patel, Elizabeth A Thiele, Robert T Wechsler, Daniel Checketts, Farhad Sahebkar
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. Epilepsia (2022)